We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
Cap. Flow
+$944M
Cap. Flow %
3.73%
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$115M
2
BSX icon
Boston Scientific
BSX
+$76.1M
3
ATR icon
AptarGroup
ATR
+$51.5M
4
HALO icon
Halozyme
HALO
+$49.1M
5
FLNC icon
Fluence Energy
FLNC
+$37M

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$53.5M
2
AVGO icon
Broadcom
AVGO
+$37.8M
3
WSC icon
WillScot Mobile Mini Holdings
WSC
+$37.5M
4
TEL icon
TE Connectivity
TEL
+$26.7M
5
NVDA icon
NVIDIA
NVDA
+$23.3M

Sector Composition

Rank Sector Weight
1 Technology 34.77%
2 Healthcare 19.94%
3 Financials 10.69%
4 Industrials 8.65%
5 Communication Services 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPC icon
1476
Pilgrim's Pride
PPC
$6.56B
$226K ﹤0.01%
+4,900
New +$207K
ADEA icon
1477
Adeia
ADEA
$3.14B
$225K ﹤0.01%
18,900
NNDM
1478
Nano Dimension
NNDM
$350M
$223K ﹤0.01%
90,900
ACH
1479
Accendra Health
ACH
$87.7M
$223K ﹤0.01%
14,200
SDGR icon
1480
Schrodinger
SDGR
$1.4B
$223K ﹤0.01%
12,000
ETWO
1481
DELISTED
E2open Parent Holdings
ETWO
$222K ﹤0.01%
50,400
+10,500
+26% +$45.9K
NABL icon
1482
N-able
NABL
$637M
$221K ﹤0.01%
+16,900
New +$226K
JAMF
1483
DELISTED
Jamf
JAMF
$217K ﹤0.01%
12,506
PYCR
1484
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
$216K ﹤0.01%
15,200
CBRL icon
1485
Cracker Barrel
CBRL
$1.3B
$212K ﹤0.01%
+4,672
New +$192K
CXM icon
1486
Sprinklr
CXM
$1.58B
$209K ﹤0.01%
27,100
+8,000
+42% +$70.4K
ARHS icon
1487
Arhaus
ARHS
$1.38B
$207K ﹤0.01%
+16,800
New +$227K
APOG icon
1488
Apogee Enterprises
APOG
$893M
$206K ﹤0.01%
+2,944
New +$189K
AGRO icon
1489
Adecoagro
AGRO
$1.33B
$205K ﹤0.01%
18,558
MCY icon
1490
Mercury Insurance
MCY
$5.86B
$205K ﹤0.01%
+3,258
New +$194K
DMC
1491
Del Monte Corp
DMC
$1.45B
$204K ﹤0.01%
+6,900
New +$183K
AUTL
1492
Autolus Therapeutics
AUTL
$593M
$203K ﹤0.01%
56,000
IBRX icon
1493
ImmunityBio
IBRX
$8.17B
$201K ﹤0.01%
53,900
AGL icon
1494
Agilon Health
AGL
$1.46B
$199K ﹤0.01%
2,028
VIR icon
1495
Vir Biotechnology
VIR
$1.55B
$198K ﹤0.01%
26,400
PLYA
1496
DELISTED
Playa Hotels & Resorts
PLYA
$196K ﹤0.01%
25,300
ZUO
1497
DELISTED
Zuora, Inc.
ZUO
$196K ﹤0.01%
22,700
BANC icon
1498
Banc of California
BANC
$3.13B
$189K ﹤0.01%
12,816
INDI icon
1499
indie Semiconductor
INDI
$856M
$185K ﹤0.01%
46,253
FSLY icon
1500
Fastly Inc
FSLY
$4.52B
$184K ﹤0.01%
24,300

Similar funds

Handelsbanken Fonder's Q3 2024 Portfolio in Review

As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.

  • Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
  • Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
  • Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
  • Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
  • Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
  • Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
  • Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.

Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.